Laguna Bio
Berkeley, California, United States
About Laguna Bio
Laguna Bio provides a drug discovery platform designed that activates and expands the innate immune system against cancer. It focuses on providing a specific type of T cell for the immune system to fight solid tumors by increasing the response rate of a bispecific antibody drug. Laguna Biotherapeutics was founded in 2022 and is headquartered in Berkeley, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Nov 2024)
- Website: lagunabio.com
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/laguna-bio-2252540 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.